Identification of sentinel lymph nodes by contrast‐enhanced ultrasonography with Sonazoid in patients with breast cancer: a feasibility study in three hospitals

@inproceedings{Shimazu2017IdentificationOS,
  title={Identification of sentinel lymph nodes by contrast‐enhanced ultrasonography with Sonazoid in patients with breast cancer: a feasibility study in three hospitals},
  author={Kenzo Shimazu and Toshikazu Ito and Kumiko Uji and Tomohiro Miyake and Toyokazu Aono and Kazuyoshi Motomura and Yasuto Naoi and Atsushi Shimomura and Masafumi Shimoda and Naofumi Kagara and Seung Jin Kim and Shinzaburo Noguchi},
  booktitle={Cancer medicine},
  year={2017}
}
The aim of this prospective study was to evaluate the feasibility of periareolar injection of the contrast agent Sonazoid (SNZ) followed by ultrasonography (US) for the identification of sentinel lymph node (SLN) in breast cancer patients with clinically negative node. Patients (n = 100) with T1-2N0M0 breast cancer received a periareolar injection of SNZ followed by US to identify contrast-enhanced SLN. Each contrast-enhanced SLN underwent fine needle aspiration cytology (FNAC) followed by SLN… CONTINUE READING

Citations

Publications citing this paper.

Axillary Nodal Staging with Contrast-Enhanced Ultrasound

  • Current Breast Cancer Reports
  • 2017
VIEW 1 EXCERPT
CITES METHODS

References

Publications referenced by this paper.
SHOWING 1-10 OF 29 REFERENCES